A number of ASX shares in the S&P/ASX 200 Health Care Index (ASX: XHJ) outperformed the broader market today.
The benchmark S&P/ASX 200 Index (ASX: XJO) backtracked yet again, ending Thursday's session 1.97% lower at 6,568.1 points.
In contrast, the healthcare sector was the best performer on the ASX today, falling just 0.19% after spending much of the day in the green.
Image source: Getty Images
What's happening in the ASX 200 healthcare sector?
The biggest and most heavily weighted share price within the ASX 200 healthcare sector is CSL Limited (ASX: CSL).
The global biotech outperformed the ASX 200, closing just 0.27% lower at $269.06. Much like the healthcare index, it was in positive territory for most of the day before retreating late in the session.
However, it was the smaller cap companies such as Paradigm Biopharmaceuticals Ltd (ASX: PAR) and Recce Pharmaceuticals Ltd (ASX: RCE) that led the charge. They gained 10.29% and 9.88%, respectively.
Paradigm reported a positive release before market open, stating it had received official acceptance of an Australian patent application. However, there was no fresh news out of Recce Pharmaceuticals.
Meanwhile, the Race Oncology Ltd (ASX: RAC) share price gained 4.84% after the company released the latest interim results from its preclinical cardioprotection program.
While the ASX 200 Health Care index has rebounded 3.2% this week, it's still down 12% year-to-date.
The ASX has been hit hard in recent weeks following high inflation levels and aggressive rate hikes.
During the March quarter, inflation rose by 5.1%, the highest increase in many years. This led the Reserve Bank of Australia to ramp up the official cash rate by 0.5% to 0.85%.
Foolish takeaway
Investing in an ASX-index tracking fund is considered a much safer alternative than picking an individual company.
This is because the sector is relatively impervious to wild swings from any one share price.
Furthermore, it's worth noting that an index has historically provided long-term stable growth.
It is often the most boring investments that reap the largest rewards.
